Will ARQT stock rebound today?

**Arcutis Biotherapeutics, Inc. (ARQT) is not expected to rebound significantly today.** Here's the analysis to support this conclusion: 1. **Recent Performance**: The stock experienced a decline, with a 1-week percentage change of -4.87% and a 1-month percentage change of 10.02%. This recent negative trend suggests that the stock may continue to face downward pressure. 2. **Short-term Trend Forecast**: The short-term trend forecast for ARQT is bullish. However, this contradicts the recent negative performance, indicating that the market sentiment may not immediately reflect the forecast. 3. **Moving Averages**: The 5-day moving average is $9.87, and the 10-day moving average is $10.24. The stock is currently trading below these short-term moving averages, which typically indicates a bearish trend. |Ticker|Name|5-Day Moving Average|10-Day Moving Average|Date|code|market_code| |---|---|---|---|---|---|---| |ARQT.O|Arcutis|9.8680|10.2400|20240724|ARQT|185| 4. **Market Sentiment**: The sentiment in the market is bearish, as evidenced by the short interest and days to cover. A high short interest and a short cover period can indicate negative sentiment. 5. **Analyst Ratings**: Despite the recent stock price decline, analysts have a consensus rating of buy, with an average price target of $19.38. This suggests that analysts believe the stock has potential to recover, but it does not guarantee immediate rebound. 6. **Upcoming Earnings Report**: The company is scheduled to release its Q2 earnings report on August 13, 2024. Investors often look ahead to earnings reports, and if the report reveals negative surprises, it could further press the stock price down. In conclusion, while the short-term trend forecast is bullish, the recent performance, market sentiment, and the lack of immediate rebound potential suggested by the forecast price and moving averages indicate that ARQT is not likely to rebound significantly today.